Nonviolent Communication Plus Personalised E-message for Parents

September 14, 2026 updated by: Dr Grace SUN Yuying, Hong Kong Metropolitan University

A Rolling Two-session Nonviolent Communication Intervention Plus Personalised E-message in Improving Child-parent Relationship: a Pilot Randomised Controlled Trial

This pilot randomised controlled trial (RCT) aims to evaluate the feasibility, acceptability, and preliminary effects of combining a brief Nonviolent Communication (NVC) intervention with follow-up personalised AI-generated messages delivered daily via WhatsApp to improve child-parent relationships, parenting competence and family communication.

A total of 60 parents of middle school students experiencing difficulties in family communication or recurrent conflict with their children will be recruited in Hong Kong and randomly assigned (in a 1:1 allocation ratio) to an intervention group or an attention control group.

The intervention group will participate in two 2-hour NVC workshops, scheduled two weeks apart and delivered by the principal investigator, plus four weeks of personalised AI-generated NVC e-messages daily. The attention control group will receive weekly e-messages with healthy lifestyle tips for 6 weeks.

Assessments for participants will be conducted at baseline (T0), post-workshop (T1, after the second session/two weeks after T0), and 12 weeks after baseline (T2). A process evaluation featuring quantitative ratings and open-ended questions will be conducted to explore participants' perceived benefits and subjective experiences.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hong Kong, Hong Kong
        • The Jockey Club Institute of Healthcare, Hong Kong Metropolitan University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 1) parents aged 32-59 years with children attending middle school (approximately 12-17 years old) in Hong Kong;
  • 2) scoring 3 or above in any item of the 3-item conflict subscale of the Network of Relationship Inventory (Furman & Buhrmester, 2009);
  • 3) able to read Chinese and use a smartphone to receive WhatsApp messages;
  • 4) willingness to attend a two-session NVC intervention in group format.

Exclusion Criteria:

  • 1) severe mental health problems requiring immediate specialist care or inability to provide informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NVC Intervention Group
Participants in the intervention group will receive two 2-hour NVC intervention workshops, scheduled two weeks apart and delivered in small groups (either online or face-to-face) by the PI, plus four weeks of daily personalised AI-generated NVC messages via WhatsApp.

The intervention includes an introduction to NVC's four principles, the difference between observations and judgments, identifying and expressing feelings, taking responsibility for feelings and needs, and using positive action language when making requests.

The intervention workshops will be offered in rolling monthly cycles for approximately three rounds over three months (two rounds will be online, and one will be face-to-face). Participants who miss the second session may attend an equivalent session in the second or third cycle. Between and following the sessions, participants will receive AI-generated, tailored messages via WhatsApp daily for four weeks that provide concise NVC tips and guide parents through NVC-style conversations with their adolescents.

Active Comparator: Attention Control Group
Participants in the attention control group will not receive any NVC intervention workshops during the study. They will receive regular healthy lifestyle information messages via WhatsApp for 6 weeks.
The attention control group will receive an information pamphlet that encourages them to maintain a healthy diet, engage in regular physical activity, and practice weight control. Participants will receive weekly WhatsApp messages about healthy lifestyle tips for 6 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: Baseline (T0)
Recruitment rate is defined as the proportion of eligible or contacted candidates who actually agree to join the study (Number Enrolled / Number Eligible or Approached).
Baseline (T0)
Retention rate
Time Frame: 12-week assessment (T2, around 3 months after baseline)
Retention rate is defined as the percentage of randomised participants retained and assessed with valid primary outcome data.
12-week assessment (T2, around 3 months after baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Child-Parent Relationship
Time Frame: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
The Child-Parent Relationship Scale (CPRS-SF) is a 15-item scale for evaluating two dimensions of the relationship between parents and children: conflict and closeness. Items are rated on a 5-point Likert scale ranging from 1 ("strongly disagree") to 5 ("strongly agree"). Scores for closeness and conflict are calculated separately, with higher closeness scores indicating a stronger emotional bond and a supportive relationship between parents and children (Driscoll & Pianta, 2011). Higher conflict scores indicate greater conflict between parents and children. The internal consistency reliabilities were adequate in a Chinese sample (Cronbach's alpha = 0.78 to 0.81) (Tan et al., 2023).
Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
Parenting Competence
Time Frame: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
The Parenting Sense of Competence Scale (PSOC) (Ngai et al., 2007) is a 17-item scale to measure parents' perceived competence in the parenting role. Each item is rated on a 6-point Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree). Higher scores indicate greater competence in parenting. Cronbach's alpha was 0.93 in a Chinese sample.
Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
Family function
Time Frame: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
The Family Communication Scale (FCS) is a 10-item scale used to measure family communication (Guo et al., 2021). Items are rated on a 5-point Likert scale, ranging from 1 ("strongly disagree") to 5 ("strongly agree"). A higher total score (range 10-50) indicates a higher level of positive family communication. The Chinese version of FCS showed good internal consistency (Cronbach's alpha = 0.91) and was stable over 1 month (intraclass correlation coefficient = 0.69).
Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
Anxiety
Time Frame: Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).
The Generalized Anxiety Disorder (GAD)-7 scale is a 7-item instrument to assess anxiety symptoms in the past two weeks (Spitzer et al., 2006; Tong et al., 2016). Each item is scored from 0 to 3. The seven item scores are summed to yield a total score ranging from 0 to 21, with higher scores indicating greater anxiety symptom severity.
Baseline (T0), Post-workshop assessment (T1, 2 weeks after T0), and 12-week assessment (T2, around 3 months after T0).

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived Benefits
Time Frame: Post-workshop assessment (T1) and 12-week assessment (T2, around 3 months after T0)
Evaluated through process evaluation metrics assessing perceived benefits, subjective changes in personal mental health, and happiness. Participants rate overall satisfaction on a 0-10 scale, with 0 indicating "very dissatisfied" and 10 indicating "very satisfied". Open-ended questions will also collect participants' comments and suggestions.
Post-workshop assessment (T1) and 12-week assessment (T2, around 3 months after T0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yuying Sun, PhD, Hong Kong Metropolitan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

September 30, 2027

Study Registration Dates

First Submitted

September 14, 2026

First Submitted That Met QC Criteria

September 14, 2026

First Posted (Actual)

September 17, 2026

Study Record Updates

Last Update Posted (Actual)

September 17, 2026

Last Update Submitted That Met QC Criteria

September 14, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

We are not sharing individual participant data (IPD) due to privacy concerns and limitations in participant consent. Although the data is de-identified, there remains a risk of re-identification, and participants were not explicitly consented for public data sharing. Aggregate results will be made available through publications and presentations to ensure transparency.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe